Drug Utilization Review (DUR) is designed to improve the quality of pharmaceutical care by ensuring that prescriptions are appropriate, medically necessary and unlikely to result in adverse medical outcomes. Medicaid’s DUR program includes prospective, online and retrospective review as well as use of standards developed by the National Council for Prescription Drug Programs (NCPDP). A board comprised of physicians and pharmacists provides guidance to Agency staff.
| 2020 Meetings |
2019 Meetings |
2018 Meetings |
2017 Meetings |
2016 Meetings |
2015 Meetings |
2014 Meetings |
| January 22, 2020 |
January 23, 2019 |
January 24,
2018 |
January 25, 2017 |
January 27, 2016 |
January 28, 2015 |
January 22, 2014 |
April 22, 2020 Meeting
Canceled
Due to Covid |
April 24, 2019 |
April 25,
2018 |
April 26,
2017 |
April 27, 2016 |
April 22,
2015 |
April 23, 2014 |
| July 22, 2020 |
July 24,
2019 |
July 25,
2018 |
July 26,
2017 |
July 27,
2016 |
July 22,
2015 |
July 23, 2014 |
| October 28, 2020 |
October 23,
2019 |
October 24,
2018
|
October 25,
2017 |
October 26,
2016 |
October 28, 2015 |
|